Impact of a Reduction in the Use of High-Risk Antibiotics on the Course of an Epidemic of Clostridium difficile-Associated Disease Caused by the Hypervirulent NAP1/027 Strain

This publication has 34 references indexed in Scilit:

• Clostridium difficileRibotype 027, Toxinotype III, the Netherlands
  Emerging Infectious Diseases, 2006
• A Predominantly Clonal Multi-Institutional Outbreak ofClostridium difficile–Associated Diarrhea with High Morbidity and Mortality
  New England Journal of Medicine, 2005
• Emergence of Fluoroquinolones as the Predominant Risk Factor for Clostridium difficile-Associated Diarrhea: A Cohort Study during an Epidemic in Quebec
  Clinical Infectious Diseases, 2005
• Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec
  CMAJ : Canadian Medical Association Journal, 2005
• Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe
  The Lancet, 2005
• Increasing Risk of Relapse after Treatment of Clostridium difficile Colitis in Quebec, Canada
  Clinical Infectious Diseases, 2005
• A Large Outbreak ofClostridium difficile–Associated Disease with an Unexpected Proportion of Deaths and Colectomies at a Teaching Hospital Following Increased Fluoroquinolone Use
  Infection Control & Hospital Epidemiology, 2005
• Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity
  CMAJ : Canadian Medical Association Journal, 2004
• Risk factors for Clostridium difficile infection
  Journal of Hospital Infection, 1998
• Hospital-wide Restriction of Clindamycin: Effect on the Incidence of Clostridium difficile-Associated Diarrhea and Cost
  Annals of Internal Medicine, 1998